BioHealth News Archive
Innovationeering: What’s your (innovation) number?
In this age of near-exclusive reliance on electronic communication, practically nobody asks for your number any longer — we just text, email or AirDrop…
Read More
Baltimore: poised for a revolution in health business | COMMENTARY – Baltimore Sun
The region’s politicians and business leaders are mourning the fact Baltimore stands to lose another headquarters of a prestigious, publicly traded company with the…
Read More
STAT Madness has begun. Vote for the best innovations in biomedicine – STAT
This is our fourth annual STAT Madness, a bracket-style tournament to find the best innovations in science and medicine. The second round of voting…
Read More
Deals News: Thermo Fisher Scientific to Buy Qiagen for $12 Bln – Bloomberg
U.S. laboratory equipment maker Thermo Fisher Scientific Inc. agreed to buy Qiagen NV, a Dutch maker of tests for diseases including cancer and the…
Read More
How to Conquer Coronavirus: Top 35 Treatments in Development
As the world scrambles to monitor and contain the COVID-19 outbreak, drug companies are racing to develop or repurpose treatments to combat the potential…
Read More
Innate Pharma
Tomorrow and every day, we recognize the hashtag#RareDisease community on behalf of the Innate Pharma team. We do what we do because of you.…
Read More
Immunomic Therapeutics Announces Completion of Pre-IND Meeting with US FDA for ITI-1001, a Vaccine for the Treatment of GBM – Bloomberg
Immunomic Therapeutics, Inc., a privately held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that it successfully completed…
Read More
CORRECTING and REPLACING Neuraly Announces First Patient Dosed in Phase 2 Clinical Trial of NLY01 for Patients with Parkinson’s Disease | Business Wire
NEURALY ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 CLINICAL TRIAL OF NLY01 FOR PATIENTS WITH PARKINSON’S DISEASE Novel Mechanism of Action Inhibits Pathological Activation…
Read More
What’s Behind Novavax’s Coronavirus/COVID-19 Vaccine Development Program · BioBuzz
The BioHealth Capital Region (BHCR) has a long history of leading the fight against new, frightening diseases, like Ebola and the novel Coronavirus (COVID-19)…
Read More
Mason to unveil a new Cyber Living Innovation Lab as part of the CCI | George Mason
A Cyber Living Innovation Lab with robotic platforms to evaluate 5G performance and a fleet of driverless cars will provide experiential learning opportunities to…
Read More
Thermo Fisher Acquiring Qiagen For €9 Billion: Details About The Deal You Should Know
As one of the largest healthcare tech deals in 2020, Thermo Fisher is buying coronavirus diagnostics company Qiagen NV for €9 billion. QIAGEN is considered…
Read More
Southern Maryland’s 6th Annual Crab Pot Pitch Competition – Speed Rounds Tickets, Thu, Apr 9, 2020 at 6:00 PM | Eventbrite
What is Crab Pot? The Crab Pot Pitch Competition is Southern Maryland’s premier pitch competition for entrepreneurs with cutting edge, disruptive and innovative technologies.…
Read More
HHS Solicits Proposals for Development of Medical Products for Novel Coronavirus | HHS.gov
As part of the government-wide effort to mitigate the spread of COVID-19 in U.S. communities, the U.S. Department of Health and Human Services (HHS)…
Read More
U.S. IPO Week Ahead: One Biotech Takes On A Turbulent IPO Market | Seeking Alpha
Facing record-high volatility and market uncertainty, one biotech is scheduled for the week ahead. Formed by New Enterprise Associate's orphan drug accelerator Cydan, genetic…
Read More
Alexandria Real Estate Equities, Inc. and Executive Chairman and Founder Joel S. Marcus Honored With the 2020 Navy SEAL Foundation Patriot Award
PASADENA, Calif. and NEW YORK, March 6, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first,…
Read More